Insider · CIK 0001238456

TERRERI PETER R

Reports to the SEC for 2 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001238456

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-05-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,459 sh	—	—	82,758
2020-05-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,459 sh	—	—	0
2019-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,107 sh	—	—	76,299
2019-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,107 sh	—	—	0
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+28K sh	—	—	28,044
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+6,459 sh	—	—	6,459
2019-03-06	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−23.3K sh	$12.39	−$289K	25,192
2019-03-06	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+45K sh	$6.55	+$295K	70,192
2019-03-06	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−45K sh	—	—	0
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+25K sh	—	—	24,977
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+6,107 sh	—	—	6,107
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−43.1K sh	—	—	0
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−5,408 sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,300 sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2018-05-04	AMRXAmneal Pharmaceuticals, Inc.A Award	Director	AAward	+48.5K sh	—	—	48,537
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10.6K sh	—	—	10,575
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10.6K sh	—	—	10,575
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+7,300 sh	—	—	7,300
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+11.5K sh	—	—	11,500
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+12K sh	—	—	12,000
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2018-05-04	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+45K sh	—	—	45,000
2017-05-16	Impax Laboratories, LLCA Award	Director	AAward	+4,375 sh	—	—	48,537
2017-05-16	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+10.6K sh	—	—	10,575
2016-05-17	Impax Laboratories, LLCA Award	Director	AAward	+4,375 sh	—	—	44,162
2016-05-17	Impax Laboratories, LLCStock Option (Right to Buy)A Award	Director	AAward	+10.6K sh	—	—	10,575
2015-08-27	Impax Laboratories, LLCS Sale	Director	SSale	−4,833 sh	$43.93	−$212K	39,787
2015-05-12	Impax Laboratories, LLCA Award	Director	AAward	+3,100 sh	—	—	44,620
2015-05-12	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+7,300 sh	—	—	7,300
2013-05-28	Impax Laboratories, LLCS Sale	Director	SSale	−666 sh	$18.89	−$12.6K	40,685
2013-05-20	Impax Laboratories, LLCS Sale	Director	SSale	−666 sh	$18.44	−$12.3K	41,351
2013-05-15	Impax Laboratories, LLCA Award	Director	AAward	+5,700 sh	—	—	42,017
2013-05-15	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2013-05-13	Impax Laboratories, LLCS Sale	Director	SSale	−666 sh	$17.44	−$11.6K	36,317
2013-05-06	Impax Laboratories, LLCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$8.00	+$60K	36,983
2013-05-06	Impax Laboratories, LLCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2013-05-01	Impax Laboratories, LLCS Sale	Director	SSale	−3,450 sh	$17.39	−$60K	29,483
2013-01-14	Impax Laboratories, LLCM Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$4.30	+$51.6K	32,933
2013-01-14	Impax Laboratories, LLCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2013-01-08	Impax Laboratories, LLCS Sale	Director	SSale	−2,500 sh	$20.95	−$52.4K	20,933

Recent filings

Accepted (ET)
May 54
TERRERI PETER R0000899243-20-012068
SEC(opens sec.gov)
May 84
TERRERI PETER R0001723128-19-000067
SEC(opens sec.gov)
Mar 74
TERRERI PETER R0001723128-19-000038
SEC(opens sec.gov)
May 84
TERRERI PETER R0001003642-18-000088
SEC(opens sec.gov)

Companies

Address

C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE

HAYWARD, CA, 94544